Evidence map›Paper›PMID 33370175›Full record

ArticleJournal of medicinal food2021

Influence of Omega-3 Fatty Acid-Rich Fish Oils on Hyperlipidemia: Effect of Eel, Sardine, Trout, and Cod Oils on Hyperlipidemic Mice.

Martha Kontostathi, Sofia Isou, Dimitrios Mostratos, Vassilios Vasdekis, Nikolaos Demertzis, Angeliki Kourounakis, Andreas Vitsos, Maria Kyriazi, Dimitrios Melissos, Charilaos Tsitouris and 10 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of medicinal food, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07004777 (Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition in Individuals With Hypertriglyceridemia. Controlled Clinical Trial.), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07004777 narecruitingnot on this mapstarted 2026, after this paper: background citation

Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition in Individuals With Hypertriglyceridemia. Controlled Clinical Trial.

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2026 to 2027Enrolled375ConditionsHypertriglyceridemiaArmsIsocaloric diet including chia and pumpkin seeds, Isocaloric diet
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Martha KontostathiSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Sofia IsouSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios MostratosDepartment of Statistics, Athens University of Economics and Business, Athens, Greece.
Vassilios VasdekisDepartment of Statistics, Athens University of Economics and Business, Athens, Greece.
Nikolaos DemertzisSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Angeliki KourounakisSection of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Andreas VitsosSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Maria KyriaziSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios MelissosQuality Assurance and Control Systems-QACS Lab, Athens, Greece.
Charilaos TsitourisQuality Assurance and Control Systems-QACS Lab, Athens, Greece.
Evangelos KaralisSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Lykourgos KlamariasKlms Veterinary Clinic, Athens, Greece.
Fotini DaniaSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Georgios-Theodorou PapaioannouSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Vassilios RoussisSection of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Evangelos PolychronopoulosDepartment of Nutrition and Dietetics, School of Health Science and Education, Harokopeion University, Athens, Greece.
Jane AnastassopoulouRadiation Chemistry and Biospectroscopy, Chemical Engineering School, National Technical University of Athens, Athens, Greece.
Theophilos TheophanidesRadiation Chemistry and Biospectroscopy, Chemical Engineering School, National Technical University of Athens, Athens, Greece.
Michail-Christou RallisSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Homer S BlackDepartment of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
National and Kapodistrian University of Athens · GRAthens University of Economics and Business · GRNational Technical University of Athens · GRSocial Insurance Institute · GRAthens Medical Center · GRBaylor College of Medicine · USHarokopio University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyslipidemia is one of the most important cardiovascular disease (CVD) risk factors. Polyunsaturated fatty acids (FAs), and especially omega-3 FAs, could significantly contribute to the management of dyslipidemia and the prevention of CVD. The anti-hyperlipidemic effect of selected fish oils (eel, sardine, trout, cod liver) was comparatively evaluated in a high fat diet (HFD)-fed mouse model. At the end of 30 days on the HFD, all animals were hyperlipidemic and were switched to a diet consisting of 90% standard rodent chow plus 10% of oil from eel, sardine, cod liver, or trout. At the end of 60 days on these diets, blood glucose, total blood cholesterol, triglycerides (TGs), and high density lipoprotein (HDL) were quantitated. All diets, except sardine and standard rodent chow, showed statistically significant decreases in blood glucose from day 30 to 90. Total blood cholesterol decreased in all diets except the HFD group, which was continued on this diet until the end of the study. Eel and cod liver oil diets showed significant decreases in TGs. All dietary groups showed a decrease in HDL, but only the trout and standard chow groups exhibited statistically significant decreases. The fish oils tested here for effects on hyperlipidemia vary in per cent of omega-3 FAs and omega-6/-3 FA ratios as determined by gas chromatography Overall, smoked eel was the best source of omega-3 FA, with a balance of omega-6 FA, that ameliorated HFD-induced mixed hyperlipidemia.

Indexed as

Fatty Acids, Omega-3HyperlipidemiasAnimalsEelsFish OilsMiceTroutFatty Acids, Omega-3Fish Oilsanti-hyperlipidemia effectdyslipidemiafish oilshigh fat dietomega-3 fatty acids

Identifiers

PMID33370175
PMCPMC8311977
OpenAlexW3115328111

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.